4974 Takara Bio
- 1123
- +13+1.17%
Takara Bio News
Takara Bio: Regarding matters related to dominant shareholders.
Takara Bio: Matters concerning the controlling shareholder.
Takara Bio: Independent Officer Notification Form
Takara Bio: Notice regarding dividends from surplus funds
Takara Bio: Consolidated financial results for the fiscal year ended 2024/3/31 (based on Japanese accounting standards)
Takara Bio: Consolidated finacial results for the nine months ended Dec 31(Under Japanese GAAP)
Takara Bio: Takara Bio Report 2022
Takara Bio: Takara Bio Report 2023
Takara Bio: Takara Bio Report 2023
Takara Bio: Grants based on emergency maintenance projects such as vaccine production systems by the Ministry of Health, Labor, and Welfare
Takara Bio: Notice Concerning Differences between the Financial Results Forecasts and the Actual Results
Takara Bio: Notice Concerning Revisions to the Financial Results Forecasts
Takara Bio: Consolidated Financial Results for the Six Months Ended September 30, 2023 (Under Japanese GAAP)
Takara Bio: {Delayed] Corporate Governance Report
Takara Bio: Consolidated Financial Results for the Three Months Ended June 30, 2023 (Under Japanese GAAP)
Takara Bio: Notice Concerning Revisions to the First Half Financial Results Forecasts
Takara Bio: [Delayed] Annual Securities Report for Fiscal Year Ended March 31, 2023
Takara Bio: Matters Concerning Controlling Shareholders
Takara Bio: Matters relating to controlling shareholders, etc.
Takara Bio: Independent Officer Notification Form
Analysis
Price Target
No Data
